VERVE THERAPEUTICS INC (VERV) Stock Balance Sheet
NASDAQ:VERV - Nasdaq - US92539P1012 - Common Stock - Currency: USD
| MRQ (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 96.55M | 172.56M | 206.18M | 115.40M | 64.30M | |||
| Marketable Securities | 400.52M | 351.72M | 417.77M | 439.40M | 296.10M | |||
| Receivables | 1.40M | 3.25M | 5.90M | 1.00M | N/A | |||
| Other Current Assets | 13.17M | 15.21M | 8.10M | 7.30M | 6.70M | |||
| Total Current Assets | 511.65M | 542.75M | 637.95M | 563.20M | 367.10M | |||
| Non-Current Assets | ||||||||
| PPE Net | 94.67M | 96.73M | 107.80M | 110.70M | 9.10M | |||
| Other Non-Current Assets | 7.84M | 7.92M | 6.94M | 5.40M | 7.90M | |||
| Total Non-Current Assets | 102.51M | 104.64M | 114.74M | 116.00M | 17.00M | |||
| TOTAL ASSETS | 614.16M | 647.39M | 752.69M | 679.20M | 384.10M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Accrued Expenses | 27.57M | 34.78M | 30.37M | 32.70M | 14.90M | |||
| Accounts Payable | 5.35M | 4.52M | 6.64M | 2.40M | 7.10M | |||
| Other Current Liabilities | 19.06M | 3.60M | N/A | N/A | 0.00 | |||
| Total Current Liabilities | 51.98M | 42.91M | 37.01M | 35.10M | 22.00M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 88.67M | 111.08M | 116.18M | 93.20M | 4.70M | |||
| Total Non-Current Liabilities | 88.67M | 111.08M | 116.18M | 93.20M | 4.80M | |||
| TOTAL LIABILITIES | 140.65M | 153.99M | 153.19M | 128.30M | 26.80M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -774.05M | -743.01M | -544.30M | -344.20M | -186.90M | |||
| Additional Paid In Capital | 1.25B | 1.24B | 1.14B | 895.80M | 544.40M | |||
| Common Shares | 89.00K | 89.00K | 82.00K | 100.00K | 0.00 | |||
| Other Shareholders' Equity | N/A | N/A | N/A | N/A | 357.35M | |||
| Shares Outstanding | 88.80M | 88.76M | 81.97M | 61.70M | 48.50M | |||
| Tangible Book Value per Share | 5.33 | 5.56 | 7.31 | 8.93 | 7.37 | |||
| Total Shareholders' Equity | 473.51M | 493.40M | 599.50M | 550.90M | 357.40M | |||
| TOTAL LIABILITIES AND EQUITY | 614.16M | 647.39M | 752.69M | 679.20M | 384.10M | |||
| Statistics | ||||||||
| Current Ratio | 9.84 | 12.65 | 17.24 | 16.05 | 16.69 | |||
| Return On Assets (ROA) | -29.47% | -30.69% | -26.58% | -23.17% | -31.32% | |||
| Return On Equity (ROE) | -38.23% | -40.27% | -33.37% | -28.57% | -33.66% | |||
All data in USD , ROIC based on taxRate of 0.21